AMRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019
17 Sep 2019
Small Cap Feast
TMT Investments PLC (TMT:LON), 313 | MS International PLC (MSI:LON), 995 | Aquis Exchange Plc (AQX:LON), 335 | Karelian Diamond Resources Plc (KDR:LON), 1.4 | ARC Minerals Limited (ARCM:LON), 1.8 | Block Energy Plc (BLOE:LON), 0.8 | 80 Mile PLC (80M:LON), 0.3 | Shearwater Group plc (SWG:LON), 35.5 | Tintra Limited (TNTAF:OTC), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
TMT Investments PLC (TMT:LON), 313 | MS International PLC (MSI:LON), 995 | Aquis Exchange Plc (AQX:LON), 335 | Karelian Diamond Resources Plc (KDR:LON), 1.4 | ARC Minerals Limited (ARCM:LON), 1.8 | Block Energy Plc (BLOE:LON), 0.8 | 80 Mile PLC (80M:LON), 0.3 | Shearwater Group plc (SWG:LON), 35.5 | Tintra Limited (TNTAF:OTC), 0
- Published:
17 Sep 2019 -
Author:
Derren Nathan - Pages:
AMRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019